Chemed (NYSE:CHE) reported quarterly earnings of $4.74 per share which beat the analyst consensus estimate of $4.65 by 1.94 percent. This is a 6.32 percent decrease over earnings of $5.06 per share from the same period last year.
Axcelis Technologies Q3 EPS $1.21 Beats $1.13 Estimate, Sales $229.18M Beat $224.38M Estimate
Axcelis Technologies (NASDAQ:ACLS) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.13 by 7.08 percent. This is a 49.38 percent increase over earnings of $0.81 per share from